AKCEA THERAPEUTICS INC's ticker is AKCA and the CUSIP is 00972L107. A total of 77 filers reported holding AKCEA THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 1.14 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $4,978,000 | +20.9% | 274,404 | -8.7% | 0.01% | +25.0% |
Q2 2020 | $4,117,000 | +736.8% | 300,504 | +773.6% | 0.00% | – |
Q1 2020 | $492,000 | -58.6% | 34,400 | -51.0% | 0.00% | -100.0% |
Q4 2019 | $1,189,000 | +164.2% | 70,200 | +265.6% | 0.00% | – |
Q2 2019 | $450,000 | – | 19,200 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BB BIOTECH AG | 2,389,571 | $61,197,000 | 1.69% |
Virtus ETF Advisers LLC | 39,351 | $1,008,000 | 0.88% |
Eventide Asset Management | 175,000 | $4,482,000 | 0.21% |
ALTRINSIC GLOBAL ADVISORS LLC | 187,800 | $4,810,000 | 0.19% |
Bellevue Group AG | 48,799 | $1,250,000 | 0.12% |
Perceptive Advisors | 97,144 | $2,488,000 | 0.07% |
FMR LLC | 10,008,016 | $256,306,000 | 0.03% |
WELLINGTON MANAGEMENT GROUP LLP | 3,384,101 | $86,667,000 | 0.02% |
Virtu Financial LLC | 12,571 | $322,000 | 0.02% |
Cubist Systematic Strategies, LLC | 7,843 | $201,000 | 0.01% |